In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than ...

It's impossible to avoid headlines about GLP-1 medications. The weight-loss drugs target hormones in the gut and brain that ...

So it was the government shutdown and some insane comments from OpenAI about a government backstop because of gigantic ...

Lucy D. Mastrandrea, MD, PhD, professor of pediatrics in the Jacobs School of Medicine and Biomedical Sciences, has been ...

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...

Shares of Amgen are up nearly 26% this year and have soared 11% just over the past week.

Did people really mean it when they said being fat is fine, and they don't want to be thin? GLP-1 drugs may be changing this ...

WASHINGTON -- Treatment with the investigational GLP-1/glucagon dual receptor agonist pemvidutide led to resolution of ...

GLP-1 receptor agonists — the drug class that includes Ozempic, Wegovy and Mounjaro — were linked to improved survival among colon cancer patients in a new observational study from UC San Diego.

Oregon and federal leaders must take a dual approach: Expanding safe, affordable access to FDA-approved anti-obesity ...

Opinion: What is Kennedy’s problem with medication?